Maryam Ahmed Sulaiman Al-Brashdi is a Senior Specialist in Medical Laboratory Sciences with extensive experience in clinical laboratory diagnostics, hematology and translational medical research.
Her current research focuses on the role of CD45 expression in acute myeloid leukemia (AML) and its impact on cellular sensitivity to chemotherapeutic agents such as cytarabine. The work aims to support more targeted and effective treatment strategies for patients with AML, with particular relevance to the Omani population.
Her professional interests include cancer biology, molecular diagnostics, personalized medicine and the optimization of therapeutic interventions through laboratory research. She is particularly interested in bridging laboratory science with clinical practice and strengthening evidence-based, patient-centered healthcare.